Call for Abstracts
Abstract Submission deadline is now passed.
Thank you for submitting your abstract for JSV 2019.
To submit an abstract, the following criteria must be met :
►The first and presenting author must be a member of the Japanese Society for Virology (JSV). Nonmembers who wish to submit abstracts should join JSV first.
►The JSV membership number is required when you submit an abstract.
Please put 007-999-9999 if you are in the process of joining JSV members.
►JSV membership is not necessarily required for those who belong to overseas facilities.
►International students in Japan should join JSV membership if they wish to submit abstracts.
►Join JSV membership through the website of The Japanese Society for Virology
|*Inquiry about JSV membership
The Japanese Society for Virology
c/o Microbiological Science, Inc.
4-13-18 Koishikawa, Bunkyo-ku, Tokyo 112-0002, Japan
1) Workshop・Oral ・Presentation time ･･･English
2) Poster ･･･English or Japanese
|Presentation Style||Abstract Title(*1)||Abstract Text||Authors(*1)||Affiliations(*1)|
*2: The presentation time may be changed depending on the number of applicants.
2. How to submit an abstract
►All abstracts should be submitted electronically through Online Abstract Submission System, Confit.
*Abstracts should not be submitted by post or e-mail.
*Browser to be used are;
•Microsoft Edge (latest version) / •Internet Explorer (latest version)
•Firefox (latest version) / •Safari (latest version) / •Chrome (latest version)
►Abstract text should be structured as follows: Objectives - Methods - Results - Discussion.
►Abstract title and text are within140 characters, and 2,000 characters reservedly.
►Please retain your login ID and password (you set your own login ID whithin 32 characters, and password between 8 and 32 characters long).
For security reasons, the secretariat is not arrowed to respond to inquiries concerning ID and passwords.
3. Abstract CategoryWithin each category (A, B, and C), please select the topic most suitable topics for your presentation.
|A03||Hepatitis Viruses(HAV, HBV, HCV, HDV and HEV)||C03||Adenoviridae|
|A05||Positive strand RNA viruses||C05||Arenaviridae|
|A06||Negative strand and ambisense RNA viruses||C06||Astroviridae|
|A07||Double-stranded RNA viruses||C07||Asfarviridae|
|A08||Others(including prions, viroids and phages)||C08||Betaherpesvirinae|
|B03||Genome and gene expression||C11||Caliciviridae|
|B04||Assembly and release||C12||Coronaviridae|
|B05||Replication of genome||C13||Filoviridae|
|B06||Viral spread and transmission||C14||Flaviviridae|
|B10||Diversity and evolution||C18||Orthomyxoviridae|
|B12||Acquired immunity and vaccines||C20||Paramyxoviridae|
|B14||Gene therapy and viral vectors||C22||Picornaviridae|
|B15||Data analysis and mathematical model||C23||Polyomaviridae|
|C27||Retroviridae (except for Lentivirus)|
►It is not permitted to present the same abstract at a scientific meeting as the one already published in scientific journals.
►One abstract will be accepted per presenter (first author).
►Co-authors are eligible to submit more than one abstract.
►Only one abstract will be accepted when the abstracts from the same group are obviously considered as one presentation.
►Please include the latest research result.
►The following abstracts will not be accepted: aim of study is not clear, irrelevant replication research, containing significant errors, gap between experiment and conclusion, and lack in moral consideration, etc.
►The program committee is responsible for reviewing all abstracts and deciding presentation style and time. If you have not received an e-mail notification, please contact the meeting secretariat.
►Notification regarding acceptance or rejection will be sent to the submitting authors’e-mail address by the end of August, 2019.
|Secretariat（c/o BlueRidge, Inc.）
Nishiazabu 3-1-17, Minato-ku, Tokyo 106-0031, Japan